Abstract
Background: Amygdalin (Vitamin B-17) is a naturally occurring vitamin found in the seeds of the fruits of Prunus Rosacea family including apricot, bitter almond, cherry, and peach.
Objective: The purpose of this study was to examine the effect of amygdalin with and without zinc on hepatocellular carcinoma (HepG2) cell line.
Methods: MTT assay was used to evaluate the cytotoxicity of amygdalin without zinc, amygdalin + 20μmol zinc, and amygdalin + 800μmol zinc on HepG2 cell lines. The cell cycle distribution assay was determined by flow cytometry. Apoptosis was confirmed by Annexin V-FITC/PI staining assay. Moreover, the pathway of apoptosis was determined by the percentage of change in the mean levels of P53, Bcl2, Bax, cytochrome c, and caspase-3.
Results: Amygdalin without zinc showed strong anti-HepG2 activity. Furthermore, HepG2 cell lines treatment with amygdalin + 20μmol zinc and amygdalin + 800μmol zinc showed a highly significant apoptotic effect than the effect of amygdalin without zinc. Amygdalin treatment induced cell cycle arrest at G2/M and increased the levels of P53, Bax, cytochrome c, and caspase-3 significantly, while it decreased the level of anti-apoptotic Bcl2.
Conclusion: Amygdalin is a natural anti-cancer agent, which can be used for the treatment of hepatocellular carcinoma. It promotes apoptosis via the intrinsic cell death pathway (the mitochondria-initiated pathway) and cell cycle arrest at G/M. The potency of amygdalin in HepG2 treatment increased significantly by the addition of zinc.
Keywords: Amygdalin, vitamin B-17, hepatocellular carcinoma, anti-cancer, Bcl2, caspase-3, P53, zinc.
Graphical Abstract
[http://dx.doi.org/10.1007/s00261-017-1209-1] [PMID: 28647765]
[http://dx.doi.org/10.3904/kjim.2014.29.2.149] [PMID: 24648795]
[PMID: 18955812]
[http://dx.doi.org/10.12691/ajcp-3-4-3]
[http://dx.doi.org/10.1002/jcb.22049] [PMID: 19160419]
[http://dx.doi.org/10.1007/978-1-61779-012-6_9] [PMID: 21318905]
[http://dx.doi.org/10.1385/1-59259-811-0:301] [PMID: 15220539]
[http://dx.doi.org/10.3892/or.2017.5450] [PMID: 28260058]
[http://dx.doi.org/10.4161/cbt.29112] [PMID: 24801380]
[PMID: 12912970]
[http://dx.doi.org/10.3389/fnagi.2017.00337] [PMID: 29089887]
[http://dx.doi.org/10.1016/j.bios.2016.09.013] [PMID: 27619529]
[http://dx.doi.org/10.1042/bj3580547] [PMID: 11535118]
[http://dx.doi.org/10.1016/0031-9422(90)85424-E]
[http://dx.doi.org/10.1016/j.carbpol.2012.05.073] [PMID: 24751072]
[http://dx.doi.org/10.1371/journal.pone.0115151] [PMID: 25502685]
[http://dx.doi.org/10.1186/s40659-015-0031-x] [PMID: 26209237]
[http://dx.doi.org/10.2147/IJN.S107021] [PMID: 27570453]
[http://dx.doi.org/10.1038/nature07986] [PMID: 19407794]
[PMID: 26408691]
[http://dx.doi.org/10.1016/j.ejca.2017.06.023] [PMID: 28756138]
[http://dx.doi.org/10.1515/BC.2006.012] [PMID: 16497168]
[http://dx.doi.org/10.1080/19768354.2015.1060261]
[http://dx.doi.org/10.1186/1476-4598-7-25] [PMID: 18331646]
[http://dx.doi.org/10.1186/1476-4598-7-25]
[http://dx.doi.org/10.4103/jomfp.JOMFP_281_18] [PMID: 31110425]
[http://dx.doi.org/10.1021/acschembio.8b00064] [PMID: 29364645]
[http://dx.doi.org/10.1074/jbc.M112.397752] [PMID: 22891250]
[http://dx.doi.org/10.1038/sj.cdd.4400772] [PMID: 11313717]
[http://dx.doi.org/10.1016/j.molcel.2009.10.011] [PMID: 19917245]
[http://dx.doi.org/10.1248/bpb.29.1597] [PMID: 16880611]
[http://dx.doi.org/10.4103/0973-1482.139743] [PMID: 25207888]
[http://dx.doi.org/10.1248/bpb.26.271] [PMID: 12576693]
[http://dx.doi.org/10.3109/08923973.2012.738688] [PMID: 23137229]
[http://dx.doi.org/10.3892/ijmm.2015.2439] [PMID: 26709398]
[http://dx.doi.org/10.1371/journal.pone.0110244] [PMID: 25333694]
[http://dx.doi.org/10.1096/fj.201700227RRR] [PMID: 28928244]